NCT01727076 2017-09-15Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Cancer, or Squamous Cell Head and Neck CancerNational Cancer Institute (NCI)Phase 1 Completed20 enrolled